In this short term, randomized, placebo controlled clinical study, which is a continuation of previously published studies [31,34], the effectiveness of CHX as an adjunct to daily plaque control on both clinical and GCF MMP-8 and TIMP-1 levels were evaluated in gingivitis patients. This evidence concerns the gene MMP8 and gingivitis.